Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter...
Agreement strengthens Edwards’ strategy to advance structural heart innovation Edwards Lifesciences (NYSE: EW) today announced it has entered...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.